Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01232491

Public ClinicalTrials.gov record NCT01232491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Randomised, Controlled, Open Label, Multicentre, Multinational, Treat to Target Trial Investigating the Impact of Dietary Intervention on Weight Change and the Relationship Between Weight Change and Baseline Body Mass Index (BMI) in Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Initiating Insulin Therapy With Insulin Detemir in Combination With Metformin (Levemir DIET)

Study identification

NCT ID
NCT01232491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
611 participants

Conditions and interventions

Interventions

  • Dietary regimen Dietary Supplement
  • Insulin detemir Drug

Dietary Supplement · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 28, 2010
Primary completion
Oct 31, 2011
Completion
Nov 13, 2011
Last update posted
Apr 30, 2017

2010 – 2011

United States locations

U.S. sites
76
U.S. states
30
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35233
Novo Nordisk Investigational Site Ozark Alabama 36360
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Burlingame California 94010
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Fullerton California 92835
Novo Nordisk Investigational Site Long Beach California 90806
Novo Nordisk Investigational Site Long Beach California 90807
Novo Nordisk Investigational Site Long Beach California 90822
Novo Nordisk Investigational Site Montclair California 91763
Novo Nordisk Investigational Site National City California 91950
Novo Nordisk Investigational Site Redlands California 92374
Novo Nordisk Investigational Site Santa Ana California 92705
Novo Nordisk Investigational Site Spring Valley California 91978
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Colorado Springs Colorado 80907
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Clearwater Florida 33765
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Jacksonville Florida 32207
Novo Nordisk Investigational Site Jupiter Florida 33458
Novo Nordisk Investigational Site Miami Florida 33135
Novo Nordisk Investigational Site Pembroke Pines Florida 33027
Novo Nordisk Investigational Site Pembroke Pines Florida 33028
Novo Nordisk Investigational Site Pembroke Pines Florida 33029
Novo Nordisk Investigational Site Atlanta Georgia 30342
Novo Nordisk Investigational Site Perry Georgia 31069
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Oympiafields Illinois 60641
Novo Nordisk Investigational Site Evansville Indiana 47714
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Louisville Kentucky 40213
Novo Nordisk Investigational Site Portland Maine 04101
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Brockton Massachusetts 02301
Novo Nordisk Investigational Site Buckley Michigan 49620
Novo Nordisk Investigational Site Southfield Michigan 48034
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site New York New York 10025
Novo Nordisk Investigational Site Northport New York 11768
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Charlotte North Carolina 28277
Novo Nordisk Investigational Site Durham North Carolina 27710
Novo Nordisk Investigational Site Raleigh North Carolina 27609
Novo Nordisk Investigational Site Wilmington North Carolina 28401
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104-5020
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site Anderson South Carolina 29621
Novo Nordisk Investigational Site Greer South Carolina 29651
Novo Nordisk Investigational Site Rapid City South Dakota 57701
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Nashville Tennessee 37212
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75251
Novo Nordisk Investigational Site Odessa Texas 79761
Novo Nordisk Investigational Site Plano Texas 75075
Novo Nordisk Investigational Site St. George Utah 84790
Novo Nordisk Investigational Site Norfolk Virginia 23502
Novo Nordisk Investigational Site Richmond Virginia 23249
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Winchester Virginia 22601
Novo Nordisk Investigational Site Spokane Washington 99208
Novo Nordisk Investigational Site Martinsburg West Virginia 25401
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01232491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01232491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →